Opioids should not be used in migraine

Headache

Volumn 52, Issue SUPPL. 1, 2012, Pages 30-34

  Tepper, Stewart J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

acute treatment; chronic migraine; migraine; narcotic; nociception; opioid

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; DYNORPHIN; GLUTAMATE RECEPTOR; MORPHINE; OPIATE;

BRAIN SIZE; CHRONIC DAILY HEADACHE; COMORBIDITY; CONFERENCE PAPER; DISEASE COURSE; DRUG EFFICACY; HEALTH CARE UTILIZATION; HUMAN; HYPERALGESIA; LOW BACK PAIN; MIGRAINE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIDE EFFECT; TRANSFORMED MIGRAINE;

ANALGESICS, OPIOID; HUMANS; MIGRAINE DISORDERS;

EID: 84860822000     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2012.02140.x     Document Type: Conference Paper

References (19)

1. Friedman BW, Grosberg BM,. Diagnosis and management of the primary headache disorders in the emergency department setting. Emerg Med Clin North Am. 2009; 27: 71-79, viii.
2. Colman I, Rothney A, Wright SC, Zilkalns B, Rowe BH,. Use of narcotic analgesics in the emergency department treatment of migraine headache. Neurology. 2004; 62: 1695-1700. (Pubitemid 38661721)
3. Tepper SJ, Martin V, Burch SP, Fu AZ, Kwong J, Downs KE,. Acute headache treatments in patients with health care coverage: What prescriptions are doctors writing? Headache Pain. 2006; 17: 11-17. (Pubitemid 44058605)
4. Tepper SJ, Dahlof C, Dowson A, et al,. Prevalence and diagnosis of migraine in patients consulting their primary care physician with a complaint of headache: Data from The Landmark Study. Headache. 2004; 44: 856-864. (Pubitemid 39362309)
5. Tepper DE, Kelley NE,. Rescue therapy for acute migraine, part 3: Opioids, NSAIDs, steroids, and post-discharge medications. Headache. 2012; 52: 467-482.
6. Dowson AJ,. Migraine: Your Questions Answered. London, UK: Churchill Livingstone; 2002.
7. Saper JR, Lake AE 3rd, Hamel RL, et al,. Daily scheduled opioids for intractable head pain: Long-term observations of a treatment program. Neurology. 2004; 62: 1687-1694. (Pubitemid 38661720)
8. Chu LF, Angst MS, Clark D,. Opioid-induced hyperalgesia in humans: Molecular mechanisms and clinical considerations. Clin J Pain. 2008; 24: 479-496.
9. Ossipov MH, Lai J, King T, et al,. Antinociceptive and nociceptive actions of opioids. J Neurobiol. 2004; 61: 126-148. (Pubitemid 39287774)
10. Meng ID, Porreca F,. Mechanisms of medication overuse headache. Headache Curr. 2004; 1: 47-54.
11. Mao J, Sung B, Ji RR, Lim G,. Neuronal apoptosis associated with morphine tolerance: Evidence for an opioid-induced neurotoxic mechanism. J Neurosci. 2002; 22: 7650-7661. (Pubitemid 35386364)
12. De Felice M, Porreca F,. Opiate-induced persistent pronociceptive trigeminal neural adaptations: Potential relevance to opiate-induced medication overuse headache. Cephalalgia. 2009; 29: 1277-1284.
13. Watkins LR, Hutchinson MR, Rice KC, Maier SF,. The "toll" of opioid-induced glial activation: Improving the clinical efficacy of opioids by targeting glia. Trends Pharmacol Sci. 2009; 30: 581-591.
14. Younger JW, Chu LF, D'Arcy NT, Trott KE, Jastrzab LE, Mackey SC,. Prescription opioid analgesics rapidly change the human brain. Pain. 2011; 152: 1803-1810.
15. Jakubowski M, Levy D, Goor-Aryeh I, Collins B, Bajwa Z, Burstein R,. Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors. Headache. 2005; 45: 850-861. (Pubitemid 41045361)
16. Ho TW, Rodgers A, Bigal ME,. Impact of recent prior opioid use on rizatriptan efficacy. A post hoc pooled analysis. Headache. 2009; 49: 395-403.
17. Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB,. Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study. Headache. 2008; 48: 1157-1168.
18. Buse DC, Pearlman SH, Serrano D, Ng-Mak DS, Reed ML, Lipton RB,. Rates of opioid use and dependence by sociodemographics, medical and psychiatric comorbidities, and headache-related disability among persons with episodic migraine (EM) in the US population: Results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache. 2011; 51 (Suppl. 1): 28-29 (abstract, Poster 59).
19. Lipton RB, Reed ML, Serrano D, Ng-Mak DS, Pearlman SH, Buse DC,. Healthcare resource utilization and associated costs by opioid use and dependence status among persons with episodic migraine (EM) in the US population: Results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache. 2011; 51 (Suppl. 1): 31-32 (abstract, Poster 67).